Research Article
GLTP Is a Potential Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Cervical Cancer
Figure 3
The prognostic value of GLTP in CC patients. (a) The survival status of CC patients from TCGA datasets. (b) Survival assays of all CC patients divided into two groups (high and low) based on the mean expression of GLTP. (c) ROC analysis of 1, 3, and 5 years. (d) LOW expression of GLTP was associated with poor prognosis of CC patients based on GSE44001 datasets.
(a) |
(b) |
(c) |
(d) |